136 related articles for article (PubMed ID: 37567386)
1. The International Association for the Study of Lung Cancer Pleural Mesothelioma Staging Project: Updated Modeling of Prognostic Factors in Pleural Mesothelioma.
Wolf AS; Rosenthal A; Giroux DJ; Nowak AK; Bille A; de Perrot M; Kindler HL; Rice D; Opitz I; Rusch VW; Pass HI; ;
J Thorac Oncol; 2023 Dec; 18(12):1689-1702. PubMed ID: 37567386
[TBL] [Abstract][Full Text] [Related]
2. Mesothelioma Risk Score: A New Prognostic Pretreatment, Clinical-Molecular Algorithm for Malignant Pleural Mesothelioma.
Yeap BY; De Rienzo A; Gill RR; Oster ME; Dao MN; Dao NT; Levy RD; Vermilya K; Gustafson CE; Ovsak G; Richards WG; Bueno R
J Thorac Oncol; 2021 Nov; 16(11):1925-1935. PubMed ID: 34242791
[TBL] [Abstract][Full Text] [Related]
3. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
Rusch VW; Venkatraman E
J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
[TBL] [Abstract][Full Text] [Related]
4. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
[TBL] [Abstract][Full Text] [Related]
5. Plasma Biomarker Enrichment of Clinical Prognostic Indices in Malignant Pleural Mesothelioma.
Pass HI; Goparaju C; Espin-Garcia O; Donington J; Carbone M; Patel D; Chen Z; Feld R; Cho J; Gadgeel S; Wozniak A; Chachoua A; Leighl N; Tsao MS; de Perrot M; Xu W; Liu G
J Thorac Oncol; 2016 Jun; 11(6):900-9. PubMed ID: 26903362
[TBL] [Abstract][Full Text] [Related]
6. Pleurectomy and decortication are associated with better survival for bicavitary cytoreductive surgery for mesothelioma compared with extrapleural pneumonectomy.
Ripley RT; Holmes HM; Whitlock RS; Groth SS; Medina CG; Choi EA; Burt BM; Sugarbaker PH
J Thorac Cardiovasc Surg; 2023 May; 165(5):1722-1730. PubMed ID: 36740497
[TBL] [Abstract][Full Text] [Related]
7. Quantitative Clinical Staging for Patients With Malignant Pleural Mesothelioma.
Gill RR; Yeap BY; Bueno R; Richards WG
J Natl Cancer Inst; 2018 Mar; 110(3):258-264. PubMed ID: 29931180
[TBL] [Abstract][Full Text] [Related]
8. A new prognostic index for overall survival in malignant pleural mesothelioma: the rPHS (regimen, PS, histology or stage) index.
Kataoka Y; Yamamoto Y; Otsuki T; Shinomiya M; Terada T; Fukuma S; Yamazaki S; Hirabayashi M; Nakano T; Fukuhara S
Jpn J Clin Oncol; 2015 Jun; 45(6):562-8. PubMed ID: 25838292
[TBL] [Abstract][Full Text] [Related]
9. Importance of excision repair cross-complementation group 1 and ribonucleotide reductase M1 as prognostic biomarkers in malignant pleural mesothelioma treated with platinum-based induction chemotherapy followed by surgery.
Frischknecht L; Meerang M; Soltermann A; Stahel R; Moch H; Seifert B; Weder W; Opitz I
J Thorac Cardiovasc Surg; 2015 Jun; 149(6):1539-46.e1. PubMed ID: 25840756
[TBL] [Abstract][Full Text] [Related]
10. Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial.
Stahel RA; Riesterer O; Xyrafas A; Opitz I; Beyeler M; Ochsenbein A; Früh M; Cathomas R; Nackaerts K; Peters S; Mamot C; Zippelius A; Mordasini C; Caspar CB; Eckhardt K; Schmid RA; Aebersold DM; Gautschi O; Nagel W; Töpfer M; Krayenbuehl J; Ribi K; Ciernik IF; Weder W
Lancet Oncol; 2015 Dec; 16(16):1651-8. PubMed ID: 26538423
[TBL] [Abstract][Full Text] [Related]
11. Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee.
Pass HI; Giroux D; Kennedy C; Ruffini E; Cangir AK; Rice D; Asamura H; Waller D; Edwards J; Weder W; Hoffmann H; van Meerbeeck JP; Rusch VW;
J Thorac Oncol; 2014 Jun; 9(6):856-64. PubMed ID: 24807157
[TBL] [Abstract][Full Text] [Related]
12. Surgery as part of radical treatment for malignant pleural mesothelioma.
Waller DA; Tenconi S
Curr Opin Pulm Med; 2017 Jul; 23(4):334-338. PubMed ID: 28590338
[TBL] [Abstract][Full Text] [Related]
13. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
[TBL] [Abstract][Full Text] [Related]
14. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
Gill RR; Richards WG; Yeap BY; Matsuoka S; Wolf AS; Gerbaudo VH; Bueno R; Sugarbaker DJ; Hatabu H
AJR Am J Roentgenol; 2012 Feb; 198(2):359-63. PubMed ID: 22268178
[TBL] [Abstract][Full Text] [Related]
15. Surgical strategy for malignant pleural mesothelioma: the superiority of pleurectomy/decortication.
Kanayama M; Mori M; Matsumiya H; Taira A; Shinohara S; Takenaka M; Kuroda K; Tanaka F
Surg Today; 2022 Jul; 52(7):1031-1038. PubMed ID: 35044520
[TBL] [Abstract][Full Text] [Related]
16. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
Flores RM; Zakowski M; Venkatraman E; Krug L; Rosenzweig K; Dycoco J; Lee C; Yeoh C; Bains M; Rusch V
J Thorac Oncol; 2007 Oct; 2(10):957-65. PubMed ID: 17909360
[TBL] [Abstract][Full Text] [Related]
17. Specimen weight and volume: important predictors of survival in malignant pleural mesothelioma.
Kircheva DY; Husain AN; Watson S; Kindler HL; Durkin A; Vigneswaran WT
Eur J Cardiothorac Surg; 2016 Jun; 49(6):1642-7. PubMed ID: 26802143
[TBL] [Abstract][Full Text] [Related]
18. The new case for cervical mediastinoscopy in selection for radical surgery for malignant pleural mesothelioma.
Nakas A; Waller D; Lau K; Richards C; Muller S
Eur J Cardiothorac Surg; 2012 Jul; 42(1):72-6; discussion 76. PubMed ID: 22290929
[TBL] [Abstract][Full Text] [Related]
19. Updates in Staging and Management of Malignant Pleural Mesothelioma.
Wolf AS; Flores RM
Surg Oncol Clin N Am; 2020 Oct; 29(4):603-612. PubMed ID: 32883461
[TBL] [Abstract][Full Text] [Related]
20. External validation of prognostic indices for overall survival of malignant pleural mesothelioma.
Kataoka Y; Yamamoto Y; Otsuki T; Kaku S; Maehashi-Wada N; Fukuma S; Hirabayashi M; Nakano T; Fukuhara S
Lung Cancer; 2017 Nov; 113():88-92. PubMed ID: 29110856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]